BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,033 | -17.2% | 360 | +45.7% | 0.00% | – |
| Q2 2023 | $1,247 | +3.0% | 247 | -61.5% | 0.00% | – |
| Q1 2023 | $1,211 | +181.6% | 641 | +168.2% | 0.00% | – |
| Q4 2022 | $430 | -57.0% | 239 | -67.5% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 735 | -2.1% | 0.00% | – |
| Q2 2022 | $1,000 | -83.3% | 751 | -61.1% | 0.00% | – |
| Q1 2022 | $6,000 | -88.7% | 1,930 | -80.7% | 0.00% | – |
| Q4 2021 | $53,000 | -53.9% | 10,005 | -26.8% | 0.00% | – |
| Q3 2021 | $115,000 | -29.4% | 13,668 | +2.2% | 0.00% | – |
| Q2 2021 | $163,000 | -99.0% | 13,379 | -98.0% | 0.00% | -100.0% |
| Q1 2021 | $16,250,000 | -23.6% | 669,854 | +0.9% | 0.00% | -20.0% |
| Q4 2020 | $21,270,000 | +52.2% | 663,633 | +43.5% | 0.01% | +25.0% |
| Q3 2020 | $13,978,000 | +16.5% | 462,387 | +62.5% | 0.00% | +33.3% |
| Q2 2020 | $11,996,000 | +2542.3% | 284,532 | +1463.7% | 0.00% | – |
| Q1 2020 | $454,000 | – | 18,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |